Stryker remains a top-tier competitor in a number of attractive medical markets, including orthopedic implants, surgical instruments, endoscopy, and neurovascular devices. It enjoys a long record ...

The global unilateral biportal endoscopy market is poised for significant growth, with sales anticipated to rise from an estimated USD 904.5 million in 2024 to an impressive USD 1,635.1 million by ...

Endoscopy had U.S. organic sales growth of ... And then the last point I would make, and we talk about this internally in Stryker all the time, the target that we're reaching for is not something ...

Stryker Corporation SYK reported third-quarter 2024 adjusted earnings per share (EPS) of $2.87, which beat the Zacks ...

The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker ...

The standing of Stryker among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ...

Stryker Corporation SYK is scheduled to release ... notably in Instruments, Medical, Endoscopy, Trauma and Extremities and Mako. The trend is likely to have continued in the third quarter.